Sertraline can reduce uremic pruritus in hemodialysis patient: A double blind randomized clinical trial from Southern Iran
Discussion: Depends on present study and previous ones, inflammation appears to play a significant role in uremic itching. Sertraline is an effective drug in reducing this complaint possibly due to its effect on reducing inflammatory cytokines. In addition there is no need to adjust sertraline dosage in patients with ESRD. Sertraline might be a treatment for patients with ESRD who do not respond to other routine drugs.
Source: Hemodialysis International - Category: Hematology Authors: Maryam Pakfetrat, Leila Malekmakan, Noushin Hashemi, Taraneh Tadayon Tags: Original Article Source Type: research
More News: Calcium | Clinical Trials | Dialysis | Hematology | Hemodialysis | Iran Health | Middle East Health | Phosphorus | Sertraline | Study | Zoloft